MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Align Technology EV/EBITDA Ratio 2011-2026 | ALGN
Annual EV/EBITDA Ratio Align Technology
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 48.9 | 84.1 | 34.3 | 34.5 | 54.1 | 24.9 | 24.8 | 19.3 | 25.1 | 16.3 | 18.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 84.1 | 16.3 | 35 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
-8.6 | $ 11.66 | 5.71 % | $ 1.75 B |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | USA |
 |
AxoGen
AXGN
|
-19.1 | $ 34.0 | 9.71 % | $ 1.57 B | USA |
 |
AdaptHealth Corp.
AHCO
|
11 | $ 12.18 | 2.01 % | $ 1.65 B | USA |
 |
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
34.5 | $ 281.15 | 1.13 % | $ 7.93 B | USA |
 |
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.62 | 1.67 % | $ 38.6 M | USA |
 |
Bruker Corporation
BRKR
|
-2.13 | $ 38.25 | 4.31 % | $ 5.7 K | USA |
 |
Boston Scientific Corporation
BSX
|
25.2 | $ 62.56 | 1.15 % | $ 92.6 B | USA |
 |
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | USA |
 |
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | USA |
 |
Electromed
ELMD
|
26.4 | $ 24.4 | 2.61 % | $ 206 M | USA |
 |
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-9.73 | $ 9.17 | 1.1 % | $ 260 M | USA |
 |
GBS
GBS
|
1.03 | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
27.6 | $ 91.96 | 2.13 % | $ 12.4 B | USA |
 |
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | USA |
 |
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | USA |
 |
Inogen
INGN
|
17.4 | $ 6.67 | -1.91 % | $ 177 M | USA |
 |
Inspire Medical Systems
INSP
|
-152 | $ 53.38 | -1.89 % | $ 1.57 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | USA |
 |
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.03 | - | $ 17.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
18.2 | $ 87.48 | 2.78 % | $ 3.04 B | USA |
 |
Invacare Corporation
IVC
|
1.89 | - | - | $ 24.7 M | USA |
 |
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-165 | $ 16.01 | 1.59 % | $ 376 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
215 | $ 64.66 | 1.76 % | $ 3.53 B |  Britain |
 |
LENSAR
LNSR
|
-1.48 | $ 5.53 | -1.78 % | $ 66.1 M | USA |
 |
Butterfly Network
BFLY
|
-3.9 | $ 4.14 | 2.22 % | $ 876 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | USA |
 |
EDAP TMS S.A.
EDAP
|
730 | $ 3.37 | -0.88 % | $ 126 M |  France |
 |
Myomo
MYO
|
-2.96 | $ 0.68 | 0.44 % | $ 28.5 M | USA |
 |
NanoVibronix
NAOV
|
0.955 | - | - | $ 1.08 M | USA |
 |
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
-1.69 | $ 9.85 | 1.86 % | $ 353 M | USA |
 |
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | USA |
 |
Natus Medical Incorporated
NTUS
|
16.2 | - | 1.94 % | $ 1.05 B | USA |
 |
Nevro Corp.
NVRO
|
-23.6 | - | - | $ 217 M | USA |